Need professional-grade analysis? Visit stockanalysis.com
$15.80B
30.99
N/A
1.38%
Shandong Weigao Blood (603014) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY37.81, up 0.51% from the previous close.
Over the past year, 603014 has traded between a low of CNY35.44 and a high of CNY46.53. The stock has lost 8.3% over this period. It is currently 18.7% below its 52-week high.
Shandong Weigao Blood has a market capitalization of $15.80B, with a price-to-earnings ratio of 30.99 and a dividend yield of 1.38%.
Shandong Weigao Blood Purification Products Co., Ltd. engages in the research and development, production, and sale of blood purification medical products in China. It offers dialyzers; dialysis machines; hemodialysis tubing, products, and machines; peritoneal dialysis products; dialysis supporting products, such as hemoperfusion devices, dialysis powder and liquid, puncture needles, and iodine caps for peritoneal dialysis. The company was founded in 2004 and is based in Weihai, China.
Side-by-side comparison against top Healthcare peers.